Recalls: cookies, dietary supplements

The following recalls have been announced:

___

Charleston Cookie Co. of Charleston, S.C., is recalling packages of almond cookies sold as part of Dean & Deluca Americana cookie tins, because they contain milk products that are not listed in the ingredients. This could be dangerous for people with milk allergies. No illness has been reported. The Americana cookie tins were sold in August through the Dean & Deluca Web site and catalog. Details: by phone at 843-762-4185.

___

Pelican Bay Ltd. is recalling all of its Caramel Chocolate Truffle Hot Chocolate Mix because the product might contain tree nuts not declared on its packaging. Those who have an allergy or severe sensitivity to tree nuts run the risk of serious or life-threatening allergic reactions if they eat the products. No illnesses have been reported to date, according to the Dunedin, Fla., company.

The recalled Caramel Chocolate Truffle Hot Chocolate Mix was distributed nationwide through direct delivery, mail order and retail stores. It was also shipped to Canada, the United Kingdom, Japan and the Netherlands. Mix distributed between January 2007 and Nov. 2, 2009, is subject to the recall. Details: by phone at 800-826-8982.

___

Bodybuilding.com LLC of Boise, Idaho, is recalling all lots and expiration dates of 65 dietary supplement products, because they could contain steroids. Steroids can cause acute liver injuries; an increased risk of heart attack, stroke and death; shrinkage of the testes; male infertility; masculinization of women; breast enlargement in males; short stature in children; an increased predilection to misuse drugs and alcohol; and adverse effects on blood lipid levels. No incidents have been reported. Details: by phone at 866-236-8417.

____

American Regent is recalling all lots of Ketorolac Tromethamine Injection, USP, 15 mg/mL, 1mL single dose vial, with the NDC number 0517-0601-25. The product is used to treat moderate to severe pain after surgical procedures. It is being recalled because it might cause obstruction of blood vessels or blood clots. It could also induce anaphylactic reactions and local irritation at the injection site and present other risks. No incidents or injuries have been reported to the company. The company said the product was distributed mainly to hospitals, clinics and health care facilities, however consumers might have been able to purchase the product with a prescription at a pharmacy. For more information, consumers can call 800-645-1706. Adverse reactions can be reported to the Food and Drug Administration at http://www.fda.gov/medwatch/report.htm . http://www.fda.gov/medwatch/report.htm

Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

< Back to News Index